UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 466

Sortiert nach

Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T‐cell therapy

British journal of haematology, 2023-07, Vol.202 (2), p.294-307

2023

Volltextzugriff (PDF)

Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives

International journal of hematology, 2018-02, Vol.107 (2), p.130-137

Matsuoka, Ken-ichi

2018

Volltextzugriff (PDF)

Collection efficiency and safety of large‐volume leukapheresis for the manufacturing of tisagenlecleucel

Transfusion (Philadelphia, Pa.), 2024-04, Vol.64 (4), p.674-684

2024

Volltextzugriff (PDF)

Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives

Frontiers in immunology, 2021-08, Vol.12, p.713358-713358

2021

Volltextzugriff (PDF)

Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation

British journal of haematology, 2024-03, Vol.204 (3), p.959-966

2024

Volltextzugriff (PDF)

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

The New England journal of medicine, 2011-12, Vol.365 (22), p.2055-2066

2011

Volltextzugriff (PDF)

Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy

British journal of haematology, 2023-11, Vol.203 (3), p.446-459

2023

Volltextzugriff (PDF)

Efficient granulocyte collection method using high concentrations of medium molecular weight hydroxyethyl starch

Transfusion (Philadelphia, Pa.), 2023-07, Vol.63 (7), p.1344-1353

2023

Volltextzugriff (PDF)

Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real‐world registry study in Japan

American journal of hematology, 2023-04, Vol.98 (4), p.E68-E71

2023

Volltextzugriff (PDF)

Low hematocrit reduces the efficiency of CD34+ cell collection when using the Spectra Optia continuous mononuclear cell collection procedure

Transfusion (Philadelphia, Pa.), 2022-05, Vol.62 (5), p.1065-1072

2022

Volltextzugriff (PDF)

Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes

Bone marrow transplantation (Basingstoke), 2021-05, Vol.56 (5), p.1126-1133

2021

Volltextzugriff (PDF)

Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group

Bone marrow transplantation (Basingstoke), 2022-03, Vol.57 (3), p.479-486

2022

Volltextzugriff (PDF)

Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein–Barr virus infection patients in Japan

American journal of hematology, 2022-06, Vol.97 (6), p.780-790

2022

Volltextzugriff (PDF)

Red blood cell depletion in small‐volume bone marrow processing using manipulation with third‐party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systems

Transfusion (Philadelphia, Pa.), 2022-09, Vol.62 (9), p.1829-1838

2022

Volltextzugriff (PDF)

Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2020-09, Vol.55 (9), p.1784-1795

2020

Volltextzugriff (PDF)

Diffuse Esophageal Wall Thickening Due to Lymphoma

Internal Medicine, 2021/10/01, Vol.60(19), pp.3179-3180

2021

Volltextzugriff (PDF)

Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression

Scientific reports, 2021-06, Vol.11 (1), p.13125-13125, Article 13125

2021

Volltextzugriff (PDF)

Endoscopic manifestation of intestinal transplant-associated microangiopathy after stem cell transplantation

BMC gastroenterology, 2024-04, Vol.24 (1), p.140-140, Article 140

2024

Volltextzugriff (PDF)

Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin

Transfusion (Philadelphia, Pa.), 2016-04, Vol.56 (4), p.886-892

2016

Volltextzugriff (PDF)

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK ‐rearranged non‐small cell lung cancer

Cancer science, 2023-11, Vol.114 (11), p.4343-4354

2023

Volltextzugriff (PDF)

Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis

Bone marrow transplantation (Basingstoke), 2021-12, Vol.56 (12), p.3008-3015

2021

Volltextzugriff (PDF)

Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group

Hematological oncology, 2023-08, Vol.41 (3), p.535-545

2023

Volltextzugriff (PDF)

Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation

Clinical cancer research, 2020-12, Vol.26 (24), p.6483-6493

2020

Volltextzugriff (PDF)

Efficacy of HLA virtual cross‐matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation

Transfusion (Philadelphia, Pa.), 2020-03, Vol.60 (3), p.473-478

2020

Volltextzugriff (PDF)

Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors

Bone marrow transplantation (Basingstoke), 2021-09, Vol.56 (9), p.2231-2240

2021

Volltextzugriff (PDF)

1 – 25 von 466

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(392)
Mit Volltextzugriff
(450)

Publikationsform

Sprache

Englisch
(452)
Japanisch
(129)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T‐cell therapy

Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives

Collection efficiency and safety of large‐volume leukapheresis for the manufacturing of tisagenlecleucel

Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives

Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy

Efficient granulocyte collection method using high concentrations of medium molecular weight hydroxyethyl starch

Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real‐world registry study in Japan

Low hematocrit reduces the efficiency of CD34+ cell collection when using the Spectra Optia continuous mononuclear cell collection procedure

Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes

Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group

Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein–Barr virus infection patients in Japan

Red blood cell depletion in small‐volume bone marrow processing using manipulation with third‐party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systems

Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation

Diffuse Esophageal Wall Thickening Due to Lymphoma

Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression

Endoscopic manifestation of intestinal transplant-associated microangiopathy after stem cell transplantation

Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK ‐rearranged non‐small cell lung cancer

Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis

Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group

Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation

Efficacy of HLA virtual cross‐matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation

Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors

Suchergebnisse filtern